This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy | MicrobiomeTrials
← Back to trials NCT07632768
Safety of Stopping Pancreatic Enzyme Replacement Therapy in Children With Improved Pancreatic Function After Highly Effective Modulator Therapy Completed NA INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2024-12-03Est. Completion: 2025-08-08
Enrollment target: 17 participantsLocations Riley Hospital for Children, Indianapolis, Indiana, United States Other microbiome trials you might be interested in Exocrine Pancreatic Insufficiency (EPI) Cystic Fibrosis (CF)
In this study, ANG003, a pancreatic enzyme replacement therapy (PERT; commonly called "enzymes"), is being investigated …
Long Beach, United States Est. completion Jul 2027
Cystic Fibrosis Pseudohypoaldosteronism Nontuberculous Mycobacterial Infection Chronic Granulomatous Disease Primary Ciliary Dyskinesia
Healthy volunteers and patients with diseases that involve problems clearing mucus from the lungs will be examined and t…
Bethesda, United States
Completed Oct 1, 2012
Cystic Fibrosis
The aim of the study is to assess the diagnostic sensitivity of MRI to detect changes in Helbich-Bhalla scoring over tim…
Bordeaux, France Completed Mar 6, 2025